Indeed, a key determinant for the ability of apoptotic or necroptotic cancer cells for efficient cross-priming of CD8+ T cells was shown not to be their type of death but rather their competence for NF-κB–driven gene expression47. This evidence concerns the gene CD8A and cancer.